DK0941075T3 - Smagsmaskerende farmaceutisk doseringsform med hurtig frigivelse - Google Patents

Smagsmaskerende farmaceutisk doseringsform med hurtig frigivelse

Info

Publication number
DK0941075T3
DK0941075T3 DK97911402T DK97911402T DK0941075T3 DK 0941075 T3 DK0941075 T3 DK 0941075T3 DK 97911402 T DK97911402 T DK 97911402T DK 97911402 T DK97911402 T DK 97911402T DK 0941075 T3 DK0941075 T3 DK 0941075T3
Authority
DK
Denmark
Prior art keywords
quick
dosage form
pharmaceutical dosage
release flavor
masking pharmaceutical
Prior art date
Application number
DK97911402T
Other languages
English (en)
Inventor
Akinori Itoh
Toshiyuki Niwa
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0941075T3 publication Critical patent/DK0941075T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
DK97911402T 1997-01-06 1997-11-20 Smagsmaskerende farmaceutisk doseringsform med hurtig frigivelse DK0941075T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB9700003 1997-01-06
PCT/IB1997/001471 WO1998030209A1 (en) 1997-01-06 1997-11-20 Rapidly releasing and taste-masking pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
DK0941075T3 true DK0941075T3 (da) 2003-07-14

Family

ID=11004515

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97911402T DK0941075T3 (da) 1997-01-06 1997-11-20 Smagsmaskerende farmaceutisk doseringsform med hurtig frigivelse

Country Status (36)

Country Link
EP (1) EP0941075B1 (da)
JP (1) JP3350059B2 (da)
KR (1) KR20000069899A (da)
CN (1) CN1244119A (da)
AP (1) AP802A (da)
AR (1) AR008553A1 (da)
AT (1) ATE238776T1 (da)
AU (1) AU715867B2 (da)
BG (1) BG103541A (da)
BR (1) BR9714253A (da)
CA (1) CA2277017C (da)
CO (1) CO4650099A1 (da)
DE (1) DE69721559T2 (da)
DK (1) DK0941075T3 (da)
EA (1) EA199900521A1 (da)
ES (1) ES2192265T3 (da)
HN (1) HN1997000151A (da)
HR (1) HRP980005A2 (da)
HU (1) HUP0002744A3 (da)
ID (1) ID21806A (da)
IL (1) IL130582A0 (da)
IS (1) IS5095A (da)
MA (1) MA26464A1 (da)
NO (1) NO993315L (da)
NZ (1) NZ336251A (da)
OA (1) OA11072A (da)
PA (1) PA8443301A1 (da)
PE (1) PE27999A1 (da)
PL (1) PL334439A1 (da)
SK (1) SK89599A3 (da)
TN (1) TNSN98002A1 (da)
TR (1) TR199901564T2 (da)
UY (1) UY24835A1 (da)
WO (1) WO1998030209A1 (da)
YU (1) YU31599A (da)
ZA (1) ZA9829B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200591B1 (en) * 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
DE19834507A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
UA67802C2 (uk) 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
EP2260836B1 (en) * 1998-11-25 2016-08-10 Cima Labs Inc. Rapid release tablet with coated drug-containing core and surrounding taste masking layer
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
NZ524572A (en) 2000-09-06 2004-08-27 Tanabe Seiyaku Co Oral compositions comprising phosphodiesterase inhibitors ( PDE inhibitor )and an acidic substance such as fumaric acid with improved drug efficacy due to decrease solubility in neutral and alkaline regions
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
SE0202365D0 (sv) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
EP1728791A4 (en) 2004-03-25 2008-12-10 Astellas Pharma Inc COMPOSITIONS FOR SOLID PHARMACEUTICAL PREPARATION OF SOLIFENACIN OR BZW. A SALT OF IT
BG66010B1 (bg) * 2004-12-08 2010-10-29 "Софарма" Ад Лекарствена форма на силденафил
DE602006020642D1 (de) * 2005-01-06 2011-04-21 Cima Labs Inc Geschmacksunterdrückungssystem für nicht weichgemachte Arzneimittel
JPWO2007010930A1 (ja) * 2005-07-20 2009-01-29 アステラス製薬株式会社 口腔内崩壊製剤用の薬物含有被覆微粒子及びその製造方法
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
JP2007031407A (ja) 2005-07-29 2007-02-08 Shin Etsu Chem Co Ltd 低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
JP4602949B2 (ja) * 2006-08-02 2010-12-22 和光堂株式会社 被覆粒子含有組成物及びその製造方法
JPWO2008059881A1 (ja) * 2006-11-14 2010-03-04 サンスター株式会社 水溶性物質で表面処理された結晶セルロースを含む口腔用組成物
JP5777273B2 (ja) * 2008-07-10 2015-09-09 大正製薬株式会社 不快な呈味を有する薬物を含有する製剤粒子
JP4706785B2 (ja) * 2008-09-30 2011-06-22 アステラス製薬株式会社 経口投与用粒子状医薬組成物
US20110244050A1 (en) 2008-12-12 2011-10-06 Siegfried Rhein S.A. De C.V. Pulsed-release sildenafil composition and method for preparing said composition
DE102009016584A1 (de) 2009-04-06 2010-10-07 Ratiopharm Gmbh Schmelztablette, enthaltend ein Sildenafil-Salz
WO2011081199A1 (ja) * 2009-12-28 2011-07-07 ニプロ株式会社 品質が向上した経口剤
JP5226732B2 (ja) * 2010-05-20 2013-07-03 エスエス製薬株式会社 催眠用圧縮成型製剤
TWI462739B (zh) * 2010-11-02 2014-12-01 Univ Kaohsiung Medical Sildenafil-同族物四級銨哌嗪鹽類之製備及醫療用途
GB201119985D0 (en) * 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
CN103271940B (zh) * 2013-05-03 2014-03-12 湖北新济药业有限公司 复方金属离子补充剂及其制备方法
WO2017146052A1 (ja) * 2016-02-23 2017-08-31 ニプロ株式会社 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法
WO2020045456A1 (ja) * 2018-08-28 2020-03-05 東和薬品株式会社 薬物含有粒子
CN113559070B (zh) * 2021-08-18 2022-12-06 广州中冠动物药业有限公司 一种适用于宠物咳嗽的药物制备方法
CN116139088B (zh) * 2023-01-31 2024-04-16 南京海纳医药科技股份有限公司 一种含有枸橼酸西地那非的干混悬剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63258809A (ja) * 1987-04-16 1988-10-26 Towa Yakuhin Kk 医薬活性成分の放出性にすぐれ、かつ苦味を隠蔽した細粒剤
EP0458751A1 (en) * 1990-05-25 1991-11-27 Warner-Lambert Company Delivery system for cyclic amino acids with improved taste, texture and compressibility
JP2576927B2 (ja) * 1992-05-15 1997-01-29 ファイザー製薬株式会社 細粒核
US5817338A (en) * 1994-07-08 1998-10-06 Astra Aktiebolag Multiple unit tableted dosage form of omeprazole

Also Published As

Publication number Publication date
CA2277017C (en) 2002-11-26
CA2277017A1 (en) 1998-07-16
YU31599A (sh) 2000-03-21
HUP0002744A3 (en) 2001-01-29
MA26464A1 (fr) 2004-12-20
PL334439A1 (en) 2000-02-28
ES2192265T3 (es) 2003-10-01
ID21806A (id) 1999-07-29
CN1244119A (zh) 2000-02-09
NZ336251A (en) 2001-01-26
BG103541A (en) 2000-03-31
EP0941075A1 (en) 1999-09-15
NO993315D0 (no) 1999-07-05
ZA9829B (en) 1999-07-05
PA8443301A1 (es) 2000-05-24
PE27999A1 (es) 1999-03-12
AU4880897A (en) 1998-08-03
JP3350059B2 (ja) 2002-11-25
WO1998030209A1 (en) 1998-07-16
HRP980005A2 (en) 1998-10-31
EP0941075B1 (en) 2003-05-02
DE69721559D1 (de) 2003-06-05
OA11072A (en) 2002-02-27
AP802A (en) 2000-01-21
TNSN98002A1 (fr) 2005-03-15
SK89599A3 (en) 2000-12-11
AR008553A1 (es) 2000-01-19
NO993315L (no) 1999-07-05
HUP0002744A2 (hu) 2000-12-28
KR20000069899A (ko) 2000-11-25
CO4650099A1 (es) 1998-09-03
JP2000514830A (ja) 2000-11-07
DE69721559T2 (de) 2003-11-27
IL130582A0 (en) 2000-06-01
IS5095A (is) 1999-06-25
AU715867B2 (en) 2000-02-10
TR199901564T2 (xx) 1999-09-21
UY24835A1 (es) 2000-09-29
EA199900521A1 (ru) 1999-12-29
BR9714253A (pt) 2000-04-18
ATE238776T1 (de) 2003-05-15
HN1997000151A (es) 1997-12-20
AP9801173A0 (en) 1998-01-31

Similar Documents

Publication Publication Date Title
DK0941075T3 (da) Smagsmaskerende farmaceutisk doseringsform med hurtig frigivelse
ID24654A (id) Formulasi farmasi omeprazola
DK1043976T3 (da) Oral farmaceutisk doseringsform med langvarig frigivelse
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
NO20020464L (no) Flerkomponents farmasöytisk doseringsform
ZA987551B (en) Solid pharmaceutical dosage forms
DK0797991T3 (da) Lægemiddelformulering med forhalet frigivelse
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
DE69525148T2 (de) Pharmazeutische formulierung
BR9506119A (pt) Composição farmacêutica e forma de dosagem farmacêutica unitária
ID23299A (id) Formulasi-formulasi farmasi
NO980546D0 (no) Farmasöytiske midler
DK1466615T3 (da) Farmaceutisk præparat
NO994619D0 (no) Farmasöytiske blandinger
ID30032A (id) Formulasi farmasi
NO20003141D0 (no) Farmasøytiske blandinger
DE19681529D2 (de) Pharmazeutische Darreichungsform
ID23531A (id) Komposisi farmasi
SE9402432D0 (sv) New pharmaceutical dosage form
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
BR9612652A (pt) Forma de administração farmacêutica
SE9803952D0 (sv) Pharmaceutical formulation
ID21180A (id) Senyawa-senyawa farmasi
GB9712357D0 (en) Pharmaceutical dosage form
IL120172A0 (en) Pharmaceutical dosage form